| pubmed-article:19476474 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19476474 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19476474 | lifeskim:mentions | umls-concept:C0024554 | lld:lifeskim |
| pubmed-article:19476474 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
| pubmed-article:19476474 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
| pubmed-article:19476474 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:19476474 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:19476474 | lifeskim:mentions | umls-concept:C0851347 | lld:lifeskim |
| pubmed-article:19476474 | lifeskim:mentions | umls-concept:C0439064 | lld:lifeskim |
| pubmed-article:19476474 | lifeskim:mentions | umls-concept:C2917389 | lld:lifeskim |
| pubmed-article:19476474 | lifeskim:mentions | umls-concept:C2746078 | lld:lifeskim |
| pubmed-article:19476474 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:19476474 | pubmed:dateCreated | 2009-7-14 | lld:pubmed |
| pubmed-article:19476474 | pubmed:abstractText | To investigate the safety, tolerability, pharmacokinetic and pharmacodynamic properties of multiple oral doses of the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin (BI 1356) in patients with type 2 diabetes mellitus. | lld:pubmed |
| pubmed-article:19476474 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19476474 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19476474 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19476474 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19476474 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19476474 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19476474 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19476474 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19476474 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19476474 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:19476474 | pubmed:issn | 1463-1326 | lld:pubmed |
| pubmed-article:19476474 | pubmed:author | pubmed-author:RingAA | lld:pubmed |
| pubmed-article:19476474 | pubmed:author | pubmed-author:DugiK AKA | lld:pubmed |
| pubmed-article:19476474 | pubmed:author | pubmed-author:HeiseTT | lld:pubmed |
| pubmed-article:19476474 | pubmed:author | pubmed-author:HüttnerSS | lld:pubmed |
| pubmed-article:19476474 | pubmed:author | pubmed-author:Trommeshauser... | lld:pubmed |
| pubmed-article:19476474 | pubmed:author | pubmed-author:Graefe-ModyE... | lld:pubmed |
| pubmed-article:19476474 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19476474 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:19476474 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19476474 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19476474 | pubmed:pagination | 786-94 | lld:pubmed |
| pubmed-article:19476474 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:19476474 | pubmed:meshHeading | pubmed-meshheading:19476474... | lld:pubmed |
| pubmed-article:19476474 | pubmed:meshHeading | pubmed-meshheading:19476474... | lld:pubmed |
| pubmed-article:19476474 | pubmed:meshHeading | pubmed-meshheading:19476474... | lld:pubmed |
| pubmed-article:19476474 | pubmed:meshHeading | pubmed-meshheading:19476474... | lld:pubmed |
| pubmed-article:19476474 | pubmed:meshHeading | pubmed-meshheading:19476474... | lld:pubmed |
| pubmed-article:19476474 | pubmed:meshHeading | pubmed-meshheading:19476474... | lld:pubmed |
| pubmed-article:19476474 | pubmed:meshHeading | pubmed-meshheading:19476474... | lld:pubmed |
| pubmed-article:19476474 | pubmed:meshHeading | pubmed-meshheading:19476474... | lld:pubmed |
| pubmed-article:19476474 | pubmed:meshHeading | pubmed-meshheading:19476474... | lld:pubmed |
| pubmed-article:19476474 | pubmed:meshHeading | pubmed-meshheading:19476474... | lld:pubmed |
| pubmed-article:19476474 | pubmed:meshHeading | pubmed-meshheading:19476474... | lld:pubmed |
| pubmed-article:19476474 | pubmed:meshHeading | pubmed-meshheading:19476474... | lld:pubmed |
| pubmed-article:19476474 | pubmed:meshHeading | pubmed-meshheading:19476474... | lld:pubmed |
| pubmed-article:19476474 | pubmed:meshHeading | pubmed-meshheading:19476474... | lld:pubmed |
| pubmed-article:19476474 | pubmed:meshHeading | pubmed-meshheading:19476474... | lld:pubmed |
| pubmed-article:19476474 | pubmed:meshHeading | pubmed-meshheading:19476474... | lld:pubmed |
| pubmed-article:19476474 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19476474 | pubmed:articleTitle | Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients. | lld:pubmed |
| pubmed-article:19476474 | pubmed:affiliation | Profil Institut für Stoffwechselforschung GmbH, Hellersbergstrasse, Neuss, Germany. | lld:pubmed |
| pubmed-article:19476474 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19476474 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:19476474 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19476474 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19476474 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19476474 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19476474 | lld:pubmed |
